相关实验视频

Updated: Jan 8, 2026

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

在乳腺癌中通过小分子共同准铁和免疫逃避

Jianbo Zhou^1,2, Wangji Yang¹, Hailin Tang³

¹West China School of Pharmacy, West China School of Medicine, Department of Thoracic Surgery and Institute of Thoracic Oncology, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.

Journal of translational internal medicine

|December 24, 2025

概括

铁死是一种独特的细胞死亡形式,为乳腺癌治疗提供了一种新的策略. 了解铁亡及其与免疫治疗的联系,可能会导致乳腺癌的新精确疗法.

科学领域:

在瘤学瘤学.
细胞死亡机制细胞死亡机制
癌症治疗癌症治疗

背景情况:

乳腺癌是全球女性癌症发病的主要原因之一.
目前用于乳腺癌亚型的精密治疗策略需要改进.
铁灭,一种独特的编程细胞死亡形式,为癌症治疗提供了一个有前途的途径.

研究的目的:

综合审查铁死在乳腺癌中的作用.
探索ferroptotic诱导剂及其与免疫疗法的相互作用.
阐明连接铁亡和瘤免疫微环境的信号通路.

主要方法:

文献综述和综合现有关于乳腺癌中铁亡的研究.
对包括小分子和自然产品在内的铁性诱导剂的分析.
研究铁灭,免疫微环境和潜在的治疗点之间的相互作用.

主要成果:

铁灭诱导是乳腺癌药物治疗的有希望的策略.
了解铁亡可以为乳腺癌提供替代治疗选择.
针对STAT3,AR,EZH2和PRMT5等调节体,可以同时诱导铁亡并克服免疫逃逸.

结论:

铁化代表了乳腺癌治疗的新且可行的策略.
进一步研究铁灭菌及其与免疫疗法的相互作用对于开发有效疗法至关重要.
准关键调节剂提供了一种双重方法来增强铁亡和提高抗瘤免疫力.

关键词:

乳腺癌乳腺癌乳腺癌铁性化 (ferroptosis) 是一种自然产品是自然产品的产品.小分子的小分子.瘤微环境是一个微环境.

更多相关视频

Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles

Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles

Published on: May 14, 2021

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...